Home > Newsletters > FDAnews Drug Daily Bulletin > Congressional Probe Into Compounding Crisis Heats Up; GAO Investigation Sought
FDAnews Drug Daily Bulletin
Oct. 25, 2012 | Vol. 9 No. 210
Congressional Probe Into Compounding Crisis Heats Up; GAO Investigation Sought
Two House Democrats asked the Government Accountability Office (GAO) to investigate the compounding pharmacy industry to look for gaps in federal and state oversight. Reps. John Tierney (Mass.) and Elijah Cummings (Md.) said they are concerned that other compounding pharmacies may have escaped regulatory scrutiny simply because they aren’t known to regulators.
Drug Industry Daily
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.